EMBR LABS INC.

Profile

Company Names

EMBR LABS INC.

Addresses

24 ROLAND STREET, SUITE 102, BOSTON, MA 02129

285 WASHINGTON STREET, SUITE C, SOMERVILLE, MA 02143

1340 CENTRE STREET, SUITE 203, NEWTON CENTER, MA 02459

Phone Numbers

833-879-3627
413-218-0629

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$14,134,042.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-10-16 
$3,000,000.00 
$6,000,000.00 
$3,000,000.00 
Equity 
3
2021-09-29 
$5,974,049.00 
$22,964,016.00 
$16,989,967.00 
Equity 
2
2019-09-06 
$5,059,993.00 
$6,000,000.00 
$940,007.00 
Equity 
1
2015-01-05 
$100,000.00 
$1,500,000.00 
$1,400,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRUCE 
E. 
CLARKE 
DIRECTOR
EMBR LABS INC.
DAVID 
 
COHEN-TANUGI 
EXECUTIVE OFFICER, DIRECTOR
EMBR LABS INC.
SHELDON 
 
ELMAN 
DIRECTOR
PERSISTENCE CAPITAL PARTNERS III (INTERNATIONAL), L.P.   |  EMBR LABS INC.   |  GLOBAL PAIN CENTER CORP.
ELIZABETH 
 
GAZDA 
EXECUTIVE OFFICER, DIRECTOR
EMBR LABS INC.
MICHAEL 
 
GIBSON 
EXECUTIVE OFFICER, DIRECTOR
EMBR LABS INC.   |  1517 FUND I, L.P.   |  1517 FUND II, L.P.   |  1517 FUND I - SPV A, L.P.   |  1517 FUND I - SPV B, L.P.   |  1517 FUND I - SPV C, L.P.   |  1517 FUND - SPV D, L.P.   |  1517 FUND - SPV E, L.P.   |  1517 FUND - SPV F, L.P.   |  1517 FUND - SPV I, L.P.   |  1517 FUND IV, L.P.
DAVID 
 
KIM 
DIRECTOR
CONTECH CONSTRUCTION PRODUCTS HOLDINGS INC   |  TV2 HOLDING CO   |  ACE LEARNING COMPANY, INC.   |  FARALLON CAPITAL PARTNERS, L.P.   |  FCOI II HOLDINGS, L.P.   |  FARALLON INVESTMENT HOLDINGS, L.P.   |  FARALLON CAPITAL (AM) INVESTORS, L.P.   |  FARALLON EUROPEAN PRIVATE CREDIT, L.P.   |  FARALLON EUROPEAN PRIVATE CREDIT MASTER, L.P.   |  FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.   |  LUMIATA, INC.   |  FARALLON CAPITAL F5 INVESTORS I, L.P.   |  FARALLON CAPITAL F5 INVESTORS II, L.P.   |  PEERNOVA, INC.   |  TISSUE ANALYTICS, INC.   |  OTC EXCHANGE NETWORK, INC.   |  REGAL HEALTHCARE CAPITAL PARTNERS, L.P.   |  NEOSENSORY, INC.   |  GRIFFITH FOODS INTERNATIONAL INC.   |  POST LTD TERM HIGH YIELD FUND, L.P.   |  POST TRADITIONAL HIGH YIELD FUND, L.P.   |  POST INTERMEDIATE TERM HIGH YIELD FUND, L.P.   |  POST SENIOR LOAN FUND, L.P.   |  EMBR LABS INC.   |  POST CREDIT OPPORTUNITIES FUND (ONSHORE), LP   |  RHCP-II QP, L.P.   |  RHCP-II, L.P.   |  SPECIAL ANESTHESIA MANAGEMENT SERVICES, LLC   |  G-TECH MEDICAL, INC.   |  USIP INVESTORS HOLDINGS, L.L.C.   |  RHCP-BUKA DERM II, LLC   |  RHCP-ABHM, LLC   |  RUNE LABS, INC.   |  VARSITY EMERGENCY CARE HOLDINGS, LLC   |  HORN BARBECUE MANDELA LLC   |  BASCOM VALUE ADDED APARTMENT INVESTORS V, LLC   |  CETERA ADVISOR NETWORKS LLC /CA   |  CETERA ADVISORS LLC /CO   |  CETERA FINANCIAL SPECIALISTS LLC   |  THRIVEWORKS TOPCO, LLC   |  NEURAL DATA TECHNOLOGIES LTD.   |  RHCP-III QP, L.P.   |  RHCP-III, L.P.   |  BASCOM VALUE ADDED APARTMENT INVESTORS VI, LLC   |  TILIA LLC
NATALIE 
 
LORENZ-ANDERSON 
DIRECTOR
EMBR LABS INC.
WILLIAM 
 
SCHROEDER 
DIRECTOR
XIRRUS INC   |  EMBR LABS INC.
SAMUEL 
 
SHAMES 
EXECUTIVE OFFICER, DIRECTOR
EMBR LABS INC.
MATTHEW 
J. 
SMITH 
EXECUTIVE OFFICER, DIRECTOR
EMBR LABS INC.   |  STRONGHOLD DIGITAL MINING, INC.
ALEX 
 
WALDRON 
DIRECTOR
PEAR THERAPEUTICS, INC.   |  EMBR LABS INC.   |  CONVEXITY SCIENTIFIC INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-10-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-16 
2021-10-07
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-29 
2019-09-17
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-06 
2015-01-16
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-01-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#